Myriad Genetics (MYGN) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Air Climate Climate Change Effluent Emission Environment Environmental Forest Green LEED Life Cycle Materials Natural Resources Nature Offset Package Pandemic Plastic Pollution Recycle Recycled Recycling Solar Waste Water Access Affordability African American Asian Benefits Black California Consumer Privacy Act Collective Bargaining Community Culture Customer Cybersecurity Data Privacy Data Security Death Demographic Disability Diversity Employee Employee Engagement Employee Resource Group Engagement Ethnic Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Human Resources Incident Injuries Injury Latinx LGBTQ Minority Opioid OSHA Overtime Perquisites Philanthropy Privacy Product Quality Recall Recruit Reimbursement Resource Group Retention Retirement Safety Satisfaction Skill Skills Social Society Stakeholder Supplier Supply Chain Talent Training Union Women Workers Workforce Working Condition Workplace Safety Anti-corruption Assessment Assurance Attorneys General Audit Board Refreshment Bonus Bribery Class Action Lawsuit Classified Classified Board Clawback Commitment Conflict of Interest Corporate Governance Corporate Purpose Corporate Social Responsibility Department of ESG Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovate Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Materiality Mission Other Public Company Boards Oversee Oversight Perquisite Plaintiff Pledging Poison Pill Purpose Quality Standard R&D Recoup Reputation Reputational Research and Development Responsibility Responsible Special Meeting Stewardship Stockholder Engagement Strategy Sustainability Sustainable Targets Tax Tenure Transparency Transparent

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 2, 2022, the Company held its Annual Meeting. Of the 80,341,255 shares of Company common stock outstanding as of the record date of April 7, 2022, a quorum of 74,478,152 shares, or approximately 93% of the outstanding shares of Company common stock, was present in person (via webcast) or represented by proxy.

The following is a brief description of each matter submitted to a vote at the Annual Meeting, as well as the number of votes cast for and against and the number of abstentions and broker non-votes with respect to each matter.

Proposal No. 1: Election of Directors

To elect Paul J. Diaz, Heiner Dreismann, Ph.D., and Colleen F. Reitan to serve until the 2025 Annual Meeting of Stockholders, and until his or her successor is duly elected and qualified or until his or her earlier death, resignation, retirement or removal.

	For		Against		Abstained	Non-Votes

	Votes		Votes		Votes	Broker
Paul J. Diaz		68,077,156		2,644,897	15,323		3,740,776
Heiner Dreismann, Ph.D.		66,782,307		3,931,557	23,512		3,740,776
Colleen F. Reitan		68,226,667		2,482,269	28,440		3,740,776

Proposal No. 2: Ratification of the Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2022

Votes

For

Against

Abstained

71,101,062

3,360,536

16,554

Proposal No. 3: Approval, on an Advisory Basis, of the Compensation of Our Named Executive Officers, as Disclosed in the Proxy Statement

For		Against		Abstained		Non-Votes

Votes		Votes		Votes		Broker
	67,116,767		3,590,907		29,702		3,740,776

Proposal No. 4: Approval of the Amended and Restated 2012 Employee Stock Purchase Plan

For		Against		Abstained		Non-Votes

Votes		Votes		Votes		Broker
	69,631,530		1,090,170		15,676		3,740,776